Search results
ACC 2025 Late-Breaking Science Collection
Video Series
Molecular Mechanisms of the Failing Heart
Added:
1 year ago
Review Article
Added:
8 months ago
Source:
Radcliffe CVRM
A secondary analysis of the SUMMIT trial has found that the benefits of tirzepatide on reducing the risk of cardiovascular death or worsening heart failure (HF) are consistent across all levels of obesity in patients with heart failure with preserved ejection fraction (HFpEF).¹ However, patients with a higher baseline body mass index (BMI) experienced greater improvements in exercise capacity and…
View more
Added:
4 months ago
Navigate the diagnostic and therapeutic landscape of autoimmune disorders and cardiomyopathy with Dr Heba WassifThis presentation, part of the comprehensive Cardiomyopathies track, explores the critical intersection between immune-mediated inflammatory disorders and cardiovascular disease.Dr Wassif examines the spectrum and epidemiology of immune-mediated inflammatory disorders, emphasizing their…
View more
Start date:
Dec 03, 2025
Severe tricuspid regurgitation (TR) remains an under-recognised and under-treated condition, stressing the importance of timely identification and referral to improve clinical outcomes.In this interactive session, Prof Marianna Adamo (University of Brescia, Brescia, IT) and Prof Volker Rudolph (Heart and Diabetes Center NRW, Bad Oeynhausen, DE) moderate an expert faculty of Prof Marta Sitges …
View more
High TnI after OPCABG
Added:
7 months ago
Original Research
Added:
7 months ago
Source:
Radcliffe Cardiology
A prespecified secondary analysis of the DANFLU-2 trial suggests that a high-dose inactivated influenza vaccine (HD-IIV) may offer greater protection against cardiovascular-related hospitalisations in older adults compared to a standard-dose vaccine (SD-IIV).¹˒² While the trial’s primary endpoint was not met, these exploratory findings point to a potential benefit in reducing the burden of…
View more
Takotsubo Syndrome in a Southeast Asian Population
Added:
10 months ago
Original Research
Added:
1 year ago
Source:
THT
THT conference has released its four late-breaking trial sessions for 2025.The fourth annual Technology and Heart Failure Therapeutics conference is set to take place from the 11th to 13th February at Omni Boston Hotel at the Seaport in Boston. Access the full programme here.Late Breaking Clinical Science Session ITuesday 11th February, 09:30 – 10:45am ESTRobotic Surgical Technique for Performing…
View more
Ramzi Ajjan
Research Area(s) / Expertise:
Job title: Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust
Author